Treatment Toxicity, Not Relapse, Explains Infant Soft Tissue Tumor Survival Gap

A population-based study involving 1102 Canadian children revealed that infants with bone and soft tissue tumors experience poorer survival rates. The study found that this survival gap is primarily due to treatment-related deaths rather than tumor relapse.

Originally published by gnews